AKUMS DRUGS & PHARMACEUTICALS
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
Sales | ₹4,014 Cr | ₹3,971 Cr | ₹3,442 Cr | ₹3,582 Cr | ₹2,638 Cr |
Job Work/ Contract Receipts | ₹57 Cr | ₹48 Cr | ₹33 Cr | ₹65 Cr | ₹52 Cr |
Processing Charges / Service Income | - | - | - | - | ₹23 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹47 Cr | ₹159 Cr | ₹180 Cr | ₹25 Cr | ₹8.95 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-1.65 Cr | ₹12 Cr | ₹24 Cr | ₹-88 Cr | ₹-30 Cr |
Raw Material Consumed | ₹2,435 Cr | ₹2,538 Cr | ₹2,250 Cr | ₹2,433 Cr | ₹1,721 Cr |
Opening Raw Materials | ₹304 Cr | ₹362 Cr | ₹335 Cr | ₹177 Cr | ₹168 Cr |
Purchases Raw Materials | ₹2,288 Cr | ₹2,221 Cr | ₹2,055 Cr | ₹2,197 Cr | ₹1,275 Cr |
Closing Raw Materials | ₹338 Cr | ₹304 Cr | ₹362 Cr | ₹335 Cr | ₹177 Cr |
Other Direct Purchases / Brought in cost | ₹181 Cr | ₹260 Cr | ₹222 Cr | ₹394 Cr | ₹455 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹164 Cr | ₹161 Cr | ₹147 Cr | ₹110 Cr | ₹77 Cr |
Electricity & Power | ₹164 Cr | ₹161 Cr | ₹147 Cr | ₹110 Cr | ₹77 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹716 Cr | ₹647 Cr | ₹590 Cr | ₹508 Cr | ₹421 Cr |
Salaries, Wages & Bonus | ₹656 Cr | ₹591 Cr | ₹541 Cr | ₹468 Cr | ₹395 Cr |
Contributions to EPF & Pension Funds | ₹23 Cr | ₹21 Cr | ₹20 Cr | ₹17 Cr | ₹15 Cr |
Workmen and Staff Welfare Expenses | ₹37 Cr | ₹34 Cr | ₹29 Cr | ₹23 Cr | ₹11 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹60 Cr | ₹68 Cr | ₹109 Cr | ₹102 Cr | ₹74 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹28 Cr | ₹36 Cr | ₹75 Cr | ₹69 Cr | ₹43 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹33 Cr | ₹31 Cr |
General and Administration Expenses | ₹141 Cr | ₹139 Cr | ₹109 Cr | ₹78 Cr | ₹52 Cr |
Rent , Rates & Taxes | ₹7.27 Cr | ₹9.20 Cr | ₹6.60 Cr | ₹5.84 Cr | ₹7.77 Cr |
Insurance | ₹5.07 Cr | ₹5.80 Cr | ₹4.66 Cr | ₹3.73 Cr | ₹2.25 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹42 Cr | ₹45 Cr | ₹47 Cr | ₹32 Cr | ₹17 Cr |
Traveling and conveyance | ₹48 Cr | ₹45 Cr | ₹50 Cr | ₹37 Cr | ₹24 Cr |
Other Administration | ₹38 Cr | ₹34 Cr | - | - | ₹0.98 Cr |
Selling and Distribution Expenses | ₹55 Cr | ₹56 Cr | ₹54 Cr | ₹52 Cr | ₹72 Cr |
Advertisement & Sales Promotion | ₹39 Cr | ₹39 Cr | ₹35 Cr | ₹29 Cr | ₹40 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹5.98 Cr | ₹7.17 Cr | ₹9.42 Cr | ₹14 Cr | ₹7.45 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹9.97 Cr | ₹9.82 Cr | ₹9.52 Cr | ₹8.26 Cr | ₹24 Cr |
Miscellaneous Expenses | ₹88 Cr | ₹434 Cr | ₹77 Cr | ₹568 Cr | ₹46 Cr |
Bad debts /advances written off | ₹0.23 Cr | ₹1.87 Cr | ₹2.46 Cr | ₹6.77 Cr | ₹5.28 Cr |
Provision for doubtful debts | ₹32 Cr | ₹12 Cr | ₹1.87 Cr | ₹13 Cr | ₹8.71 Cr |
Losson disposal of fixed assets(net) | ₹0.15 Cr | ₹0.33 Cr | ₹0.16 Cr | ₹3.09 Cr | ₹0.69 Cr |
Losson foreign exchange fluctuations | ₹0.32 Cr | ₹0.09 Cr | ₹5.77 Cr | ₹0.47 Cr | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹55 Cr | ₹421 Cr | ₹67 Cr | ₹545 Cr | ₹31 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹3,658 Cr | ₹4,055 Cr | ₹3,361 Cr | ₹3,764 Cr | ₹2,431 Cr |
Operating Profit (Excl OI) | ₹461 Cr | ₹123 Cr | ₹294 Cr | ₹-92 Cr | ₹291 Cr |
Other Income | ₹56 Cr | ₹34 Cr | ₹90 Cr | ₹23 Cr | ₹21 Cr |
Interest Received | ₹25 Cr | ₹12 Cr | ₹7.88 Cr | ₹4.63 Cr | ₹6.14 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.04 Cr | ₹0.02 Cr | ₹6.97 Cr | ₹2.08 Cr | ₹1.28 Cr |
Profits on sale of Investments | - | - | - | - | ₹0.08 Cr |
Provision Written Back | ₹7.95 Cr | ₹5.55 Cr | ₹22 Cr | ₹3.24 Cr | ₹3.22 Cr |
Foreign Exchange Gains | ₹4.48 Cr | ₹7.29 Cr | ₹1.88 Cr | ₹3.12 Cr | ₹4.74 Cr |
Others | ₹19 Cr | ₹9.16 Cr | ₹52 Cr | ₹9.56 Cr | ₹5.70 Cr |
Operating Profit | ₹517 Cr | ₹157 Cr | ₹384 Cr | ₹-69 Cr | ₹312 Cr |
Interest | ₹35 Cr | ₹51 Cr | ₹46 Cr | ₹17 Cr | ₹6.74 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹24 Cr | ₹43 Cr | ₹40 Cr | ₹8.45 Cr | ₹2.90 Cr |
Intereston Fixed deposits | ₹0.10 Cr | ₹0.07 Cr | ₹0.10 Cr | ₹0.15 Cr | ₹0.23 Cr |
Bank Charges etc | ₹4.19 Cr | ₹0.36 Cr | ₹0.27 Cr | ₹0.32 Cr | ₹0.36 Cr |
Other Interest | ₹6.34 Cr | ₹7.18 Cr | ₹5.80 Cr | ₹7.75 Cr | ₹3.26 Cr |
PBDT | ₹482 Cr | ₹106 Cr | ₹338 Cr | ₹-86 Cr | ₹306 Cr |
Depreciation | ₹153 Cr | ₹126 Cr | ₹113 Cr | ₹95 Cr | ₹70 Cr |
Profit Before Taxation & Exceptional Items | ₹329 Cr | ₹-19 Cr | ₹225 Cr | ₹-180 Cr | ₹236 Cr |
Exceptional Income / Expenses | ₹17 Cr | ₹-26 Cr | ₹-75 Cr | ₹-13 Cr | ₹-64 Cr |
Profit Before Tax | ₹345 Cr | ₹-45 Cr | ₹150 Cr | ₹-193 Cr | ₹172 Cr |
Provision for Tax | ₹1.48 Cr | ₹-46 Cr | ₹52 Cr | ₹58 Cr | ₹49 Cr |
Current Income Tax | ₹81 Cr | ₹74 Cr | ₹78 Cr | ₹69 Cr | ₹55 Cr |
Deferred Tax | ₹-79 Cr | ₹-103 Cr | ₹-27 Cr | ₹-6.04 Cr | ₹-6.47 Cr |
Other taxes | ₹-0.46 Cr | ₹-17 Cr | ₹1.61 Cr | ₹-5.33 Cr | - |
Profit After Tax | ₹344 Cr | ₹0.79 Cr | ₹98 Cr | ₹-251 Cr | ₹123 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-5.60 Cr | ₹-4.83 Cr | ₹-2.96 Cr | ₹-1.66 Cr | ₹-0.73 Cr |
Share of Associate | - | - | - | - | ₹0.35 Cr |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹338 Cr | ₹-4.04 Cr | ₹95 Cr | ₹-253 Cr | ₹123 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹631 Cr | ₹639 Cr | ₹558 Cr | ₹832 Cr | ₹771 Cr |
Appropriations | ₹969 Cr | ₹635 Cr | ₹652 Cr | ₹580 Cr | ₹893 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹-860 Cr | ₹3.66 Cr | ₹14 Cr | ₹22 Cr | ₹61 Cr |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹22.09 | ₹-0.28 | ₹6.63 | ₹-35.30 | ₹943.16 |
Adjusted EPS | ₹22.09 | ₹-0.28 | ₹6.63 | ₹-17.65 | ₹8.57 |
Compare Income Statement of peers of AKUMS DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AKUMS DRUGS & PHARMACEUTICALS | ₹8,708.2 Cr | 0.3% | 2.4% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AKUMS DRUGS & PHARMACEUTICALS | 0.3% |
2.4% |
|
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses